Oxidative stress and macrophage foam cell formation during diabetes mellitus-induced atherogenesis: Role of insulin therapy

Pharmacology and Therapeutics

Volumn 136, Issue 2, 2012, Pages 175-185

  Kaplan, Marielle ^a   Aviram, Michael ^a   Hayek, Tony ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Atherosclerosis; Cholesterol; Diabetes mellitus; Insulin; Oxidative stress; Paraoxonases

Indexed keywords

APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; CD36 ANTIGEN; CHOLESTEROL; DIACYLGLYCEROL ACYLTRANSFERASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANTIGEN EXPRESSION; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BIOACCUMULATION; CARDIOVASCULAR DISEASE; CHOLESTEROL SYNTHESIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; DYSLIPIDEMIA; ENZYME INHIBITION; FOAM CELL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; LIPID PEROXIDATION; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CHOLESTEROL; DIABETES COMPLICATIONS; FOAM CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INSULIN; LIPID PEROXIDATION; LIPOPROTEINS, LDL; OXIDATIVE STRESS; TRIGLYCERIDES;

EID: 84867335958     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.08.002     Document Type: Review

References (114)

1. A. Abaci, A. Oǧuzhan, S. Kahraman, N.K. Eryol, S. Unal, and H. Arinc Effect of diabetes mellitus on formation of coronary collateral vessels Circulation 99 1999 2239 2242
2. C.A. Abbott, M.I. Mackness, S. Kumar, A.J. Boulton, and P.N. Durrington Serum paraoxonase activity, concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoprotein Arterioscler Thromb Vasc Biol 11 1995 1812 1818
3. F.K. Ahmad, H. Zhiheng, and G.L. King Molecular targets of diabetic cardiovascular complications Curr Drug Targets 6 2005 487 494
4. T. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients Ann Thorac Surg 86 2008 20 27
5. A. Aljada, and P. Dandona Effect of insulin on human aortic endothelial nitric oxide synthase Metabolism 49 2000 147 150
6. A. Aljada, H. Ghanim, R. Saadeh, and P. Dandona Insulin inhibits NF-kappaB and MCP-1 expression in human aortic endothelial cells J Clin Endocrinol Metab 86 2001 450 453
7. American Diabetes Association Nutrition Principles and Recommendations in Diabetes Diabetes Care 27 Suppl. 1 2004, January s36
8. M.A. Atkinson, and G.S. Eisenbarth Type 1 diabetes: New perspectives on disease pathogenesis and treatment Lancet 358 2001 221 229
9. M. Aviram Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins Antioxid Redox Signal 1 1999 585 594
10. M. Aviram, L. Dornfeld, M. Rosenblat, N. Volkova, M. Kaplan, and R. Coleman Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: Studies in humans and in atherosclerotic apolipoprotein E-deficient mice Am J Clin Nutr 71 2000 1062 1076
11. M. Aviram, and B. Fuhrman Wine flavonoids protect against LDL oxidation and atherosclerosis Ann N Y Acad Sci 957 2002 146 161
12. M. Aviram, and M. Rosenblat Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development Free Radic Biol Med 37 2004 1304 1316
13. M. Aviram, and M. Rosenblat Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences Curr Opin Lipidol 16 2005 393 399
14. M. Aviram Hyperlipidaemia and cardiovascular disease: Inflammation andoxidative stress in diabetic patients Curr Opin Lipidol 20 2009 258 259
15. A. Avogaro, S.V. de Kreutzenberg, and G.P. Fadini Oxidative stress and vascular disease in diabetes: Is the dichotomization of insulin signaling still valid? Free Radic Biol Med 44 2008 1209 1215
16. G. Basta, A.M. Schmidt, and R. De Caterina Advanced end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 2004 582 592
17. S. Blum, M. Vardi, J.B. Brown, A. Russell, U. Milman, and C. Shapira Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype Pharmacogenomics 11 2010 675 684
18. S. Boura-Halfon, and Y. Zick Phosphorylation of IRS proteins, insulin action, and insulin resistance Am J Physiol Endocrinol Metab 296 2009 E581 E591
19. M.S. Brown, and J.L. Goldstein The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340
20. A.M. Brown, and G.F. Gibbons Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event Arterioscler Thromb Vasc Biol 21 2001 1656 1661
21. M. Brownlee Biochemistry of and molecular biology of diabetic complications Nature 414 2001 813 820
22. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
23. W. Cao, J. Ning, X. Yang, and Z. Liu Excess exposure to insulin is the primary cause of insulin resistance and its associated atherosclerosis Curr Mol Pharmacol 4 2011 154 166
24. C. Cardillo, S.S. Nambi, C.M. Kilcoyne, W.K. Choucair, A. Katz, and M.J. Quon Insulin stimulates both endothelin and nitric oxide activity in the human forearm Circulation 100 1999 820 825
25. R. Carmena, P. Duriez, and J.C. Fruchart Atherogenic lipoprotein particles in atherosclerosis Circulation 109 2004 III2 III7
26. A. Ceriello, and R. Testa Antioxidant anti-inflammatory treatment in type 2 diabetes Diabetes Care 32 2009 S232 S236
27. A. Chait, and K.E. Bornfeldt Diabetes and atherosclerosis: Is there a role for hyperglycemia? J Lipid Res 50 2009 S335 S339
28. B. Chertow Advances in diabetes for the millennium: Vitamins and oxidant stress in diabetes and its complications MedGenMed 6 Suppl. 3 2004 4
29. D.V. Chirieac, J. Cianci, H.L. Collins, J.D. Sparks, and C.E. Sparks Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor Biochem Biophys Res Commun 297 2002 134 137
30. M.H. Cummings, G.F. Watts, A.M. Umpleby, T.R. Hennessy, J.M. Kelly, and N.C. Jackson Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM Diabetes 44 1995 1059 1065
31. P. Dandona, A. Aljada, P. Mohanty, H. Ghanim, W. Hamouda, and E. Assian Insulin inhibits intranuclear nuclear factor kappaB and stimulates I-kappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86 2001 3257 3265
32. P. Dandona, A. Chaudhuri, P. Mohanty, and H. Ghanim Anti-inflammatory effects of insulin Curr Opin Clin Nutr Metab Care 10 2007 511 517
33. J.P. Després, B. Lamarche, P. Mauriège, B. Cantin, G.R. Dagenais, and S. Moorjani Hyperinsulinemia as an independent risk factor for ischemic heart disease N Engl J Med 334 1996 952 957
34. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
35. X. Du, D. Edelstein, S. Obici, N. Higham, M.H. Zou, and M. Brownlee Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation J Clin Invest 116 2006 1071 1080
36. L. Duvillard, F. Pont, E. Florentin, P. Gambert, and B. Vergès Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus Diabetologia 43 1 2000 27 35
37. J.L. Evans, I.D. Goldfine, B.A. Maddux, and G.M. Grodsky Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes Endocr Rev 23 2002 599 622
38. K.R. Feingold Importance of small intestine in diabetic hypercholesterolemia Diabetes 38 1989 141 145
39. M. Fisher Diabetes and atherogenesis Heart 90 2004 336 340
40. A. Gantman, B. Fuhrman, M. Aviram, and T. Hayek High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx Biochem Biophys Res Commun 391 2010 523 528
41. P. Geraldes, K. Yagi, Y. Ohshiro, Z. He, Y. Maeno, and J. Yamamoto-Hiraoka Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/ phosphoinositide 3-kinase/Akt2 pathway J Biol Chem 283 2008 34327 34336
42. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ Res 107 2010 1058 1070
43. M.L. Gil, F.A. Tomas-Barberan, B. Hess-Pierce, D.M. Holcroft, and A.A. Kader Antioxidant activity of pomegranate juice and its relationship with phenolics composition and processing J Agric Food Chem 10 2000 4581 4589
44. H.N. Ginsberg, and L.S. Huang The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis J Cardiovasc Risk 7 2000 325 331
45. H.E. Grenett, R.L. Benza, G.M. Fless, X.N. Li, G.C. Davis, and F.M. Booyse Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells Arterioscler Thromb Vasc Biol 18 1998 1803 1809
46. M.P. Habib, F.D. Dickerson, and A.D. Mooradian Effect of diabetes, insulin and glucose load on lipid peroxidation in the rat Metabolism 43 1994 1442 1445
47. T. Hayek, K. Hussein, M. Aviram, R. Coleman, S. Keidar, and E. Pavoltzky Macrophage-foam cell formation in streptozotocin-induced diabetic mice: Stimulatory effect of glucose Atherosclerosis 183 2005 25 33
48. T. Hayek, M. Kaplan, R. Kerry, and M. Aviram Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for d-glucose Atherosclerosis 195 2007 277 286
49. E.J. Henriksen, M.K. Diamond-Stanic, and E.M. Marchionne Oxidative stress and the etiology of insulin resistance and type 2 diabetes Free Radic Biol Med 51 2011 993 999
50. C. Hermann, B. Assmus, C. Urbich, A.M. Zeiher, and S. Dimmeler Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells Arterioscler Thromb Vasc Biol 20 2000 402 409
51. K.S. Hirano, Y. Yamashita, T. Nakagawa, F. Ohya, K. Matsuura, and Tsukamoto Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions Circ Res 85 1999 108 116
52. R.R. Holman, S.K. Paul, M.A. Bethel, H.A. Neil, and D.R. Matthews 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
53. J.D. Horton, I. Shimomura, and M.S. Brown Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2 J Clin Invest 101 1998 2331 2339
54. W. Jessup, I.C. Gelissen, K. Gaus, and L. Kritharides Roles of ATP binding cassette transporters A1 and G1 scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages Curr Opin Lipidol 17 2006 247 257
55. M. Kaplan, and M. Aviram Ox-LDL atherogenic and proinflammatory characteristics during macrophage foam cell formation: An inhibitory role for nutritional antioxidants and serum paraoxonase Clin Chem Lab Med 37 1999 777 787
56. M. Kaplan, R. Kerry, M. Aviram, and T. Hayek High glucose concentration increases macrophage cholesterol biosynthesis in diabetes through activation of the sterol regulatory element binding protein 1 (SREBP1): Inhibitory effect of insulin J Cardiovasc Pharmacol 52 2008 324 332
57. D.T. Karamitsos Antiatheromatic effects of insulin Diabetes Res Clin Pract 93 Suppl. 1 2011 S105 S108
58. H.M. Knott, B.E. Brown, M.J. Davies, and R.T. Dean Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles Eur J Biochem 270 2003 3572 3582
59. A. Kondo, M. Manabe, K. Saito, M. Maekawa, and T. Kanno Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes J Atheroscler Thromb 9 2002 280 287
60. M. Koren-Gluzer, M. Aviram, E. Meilin, and T. Hayek The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release Atherosclerosis 219 2011 510 518
61. M. Krieger Charting the fate of the good cholesterol: Identification and characterization of the high-density lipoprotein receptor SR-BI Annu Rev Biochem 68 1999 523 558
62. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase J Clin Invest 89 1992 1006 1013
63. K. Kuboki, Z.Y. Jiang, N. Takahara, S.W. Ha, M. Igarashi, and T. Yamauchi Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin Circulation 101 2000 676 681
64. P. Kyselová, M. Zourek, Z. Rusavý, L. Trefil, and J. Racek Hyperinsulinemia and oxidative stress Physiol Res 51 2002 591 595
65. C.P. Liang, S. Han, R.C. Okamoto, I. Tabas, D. Accili, and A.R. Tall Increased CD36 protein as a response to defective insulin signaling in macrophages J Clin Invest 113 2004 764 773
66. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
67. B. Mackness, P. McElduff, and M.I. Mackness The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus J Intern Med 258 2005 363 368
68. R. Madonna, A. Pandolfi, M. Massaro, A. Consoli, and R. De Caterina Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase Diabetologia 47 2004 532 536
69. R. Malmström, C.J. Packard, M. Caslake, D. Bedford, P. Stewart, and H. Yki-Järvinen Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM Diabetologia 40 1997 454 462
70. P. Martin-Gallan, A. Carrascosa, M. Gussinye, and C. Dominguez Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications Free Radic Biol Med 34 2003 1563 1574
71. M. Mastorikou, M. Mackness, and B. Mackness Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes Diabetes 55 2006 3099 3103
72. M. Mastorikou, B. Mackness, Y. Liu, and M. Mackness Glycation of paraoxonase 1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides Diabet Med 25 2008 1049 1055
73. D.R. Matthews, and P.C. Matthews Banting Memorial Lecture 2010. Type 2 diabetes as an 'infectious' disease: Is this the Black Death of the 21st century? Diabet Med 28 1 2011 2 9
74. C. Maziere, M. Auclair, F. Rose-Robert, P. Leflon, and J.C. Maziere Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation FEBS Lett 363 1995 277 279
75. T. Mazzone, D. Foster, and A. Chait In vivo stimulation of low-density lipoprotein degradation by insulin Diabetes 33 1984 333 338
76. E. Meilin, M. Aviram, and T. Hayek Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: Studies in PON2-deficient mice Atherosclerosis 208 2010 390 395
77. E. Meilin, M. Aviram, and T. Hayek Insulin increases macrophage triglyceride accumulation under diabetic conditions through the down regulation of hormone sensitive lipase and adipose triglyceride lipase Biofactors 37 2011 95 103
78. N. Mikhail, and M.L. Tuck Insulin and the vasculature Curr Hypertens Rep 2 2000 148 153
79. D.M. Muoio, and C.B. Newgard Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes Nat Rev Mol Cell Biol 9 2008 193 205
80. S. Nandish, O. Bailon, J. Wyatt, J. Smith, A. Stevens, and M. Lujan Vasculotoxic effects of insulin and its role in atherosclerosis: What is the evidence? Curr Atheroscler Rep 13 2011 123 128
81. C.J. Ng, D.M. Shih, S.Y. Hama, N. Villa, M. Navab, and S.T. Reddy The paraoxonase gene family and atherosclerosis Free Radic Biol Med 38 2005 153 163
82. A. Norhammar, A. Tenerz, G. Nilsson, A. Hamsten, S. Efendíc, and L. Rydén Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study Lancet 359 2002 2140 2144
83. N. Ohgami, A. Miyazaki, M. Sakai, A. Kuniyasu, H. Nakayama, and S. Horiuchi Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: A new crossroad of AGE to cholesterol metabolism J Atheroscler Thromb 10 2003 1 6
84. C.T. Prince, D.J. Becker, T. Costacou, R.G. Miller, and T.J. Orchard Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC) Diabetologia 50 2007 2280 2288
85. A. Quiñones-Galvan, E. Muscelli, C. Catalano, A. Natali, G. Sanna, and A. Masoni Insulin decreases circulating vitamin E levels in humans Metabolism 45 1996 998 1003
86. A. Quiñones-Galvan, A.M. Sironi, S. Baldi, F. Galetta, U. Garbin, and A. Fratta-Pasini Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans Arterioscler Thromb Vasc Biol 19 1999 2928 2932
87. J.L. Rains, and S.K. Jain Oxidative stress, insulin signaling, and diabetes Free Radic Biol Med 50 2011 567 575
88. C. Rask-Madsen, Q. Li, B. Freund, D. Feather, R. Abramov, and I.H. Wu Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice Cell Metab 11 5 2010 379 389
89. G.M. Reaven Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
90. V. Robert, Jr Farese, C. Sylvaine, and S.J. Smith Triglyceride synthesis: Insights from the cloning of diacylglycerol acyltransferase Curr Opin Lipidol 11 2000 229 234
91. G. Romano, L. Patt,i, F. Innelli, L. Di Marino, G. Annuzzi, and M. Iavicoli Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control? Diabetes 46 1997 1601 1606
92. M. Rosenblat, and M. Aviram Paraoxonases role in the prevention of cardiovascular diseases Biofactors 35 2009 98 104
93. M. Rosenblat, R. Coleman, S.T. Reddy, and M. Aviram Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 (DGAT1), the rate limiting enzyme in triglyceride biosynthesis J Lipid Res 50 2009 870 879
94. M. Rosenblat, T. Hayek, and M. Aviram Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages Atherosclerosis 187 2006 363 371
95. M. Rosenblat, R. Karry, and M. Aviram Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: Relevance to diabetes Atherosclerosis 187 2006 74 81
96. O. Rozenberg, M. Shiner, M. Aviram, and T. Hayek Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties Free Radic Biol Med 44 2008 1951 1959
97. S. Rustaeus, P. Stillemark, K. Lindberg, D. Gordon, and S.V. Olofsson The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells J Biol Chem 273 1998 5196 5203
98. M. Schwiger, R. Schreiber, G. Haemmerle, A. Lass, C. Fledelius, and P. Jacobsen Adipose triglyceride lipase and hormone sensitive lipase are the major enzymes in adipose triacylglycerol catabolism J Biol Chem 281 2006 40236 40241
99. R. Shamir, N. Shehadeh, M. Rosenblat, O. Eshach-Adiv, R. Coleman, and M. Kaplan Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 2003 104 110
100. H. Shimano Sterol regulatory element binding proteins transcriptional regulators of lipid synthetic genes Prog Lipid Res 40 2001 439 452
101. D. Sparks, T.L. Phung, M. Bolognino, and C.E. Sparks Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: Studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes Biochem J 313 1996 567 574
102. E. Standl, M. Müller, and O. Schnell The impact of glucose-lowering therapy on cardiovascular outcomes Best Pract Res Clin Endocrinol Metab 23 2009 401 411
103. H.O. Steinberg, G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release J Clin Invest 94 1994 1172 1179
104. R.W. Stout Hyperinsulinemia and atherosclerosis Diabetes 45 Suppl. 3 1996 S45 S46
105. N. Suksomboon, N. Poolsup, and S. Sinprasert Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: Systematic review of randomized controlled trials J Clin Pharm Ther 36 2011 53 63
106. A.R. Tall Cholesterol efflux pathways and other potential mechanisms involved in the atheroprotective effect of high density lipoprotein J Intern Med 263 2008 256 273
107. G.H. Tomkin Atherosclerosis, diabetes and lipoproteins Expert Rev Cardiovasc Ther 8 2010 1015 1029
108. M. Van Eck, M. Pennings, M. Hoekstra, R. Out, and T.J. Van Berkel Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis Curr Opin Lipidol 16 2005 307 315
109. S.K. Venugopal, S. Devaraj, T. Yang, and I. Jialal Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha Diabetes 51 2002 3049 3054
110. R.K. Vikramadithyan, Y. Hu, H.L. Noh, C.P. Liang, K. Hallam, and A.R. Tall Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice J Clin Invest 2005 2005 2434 2443
111. A. Von Eckardstein, and R.A. Sibler Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2 Curr Opin Lipidol 22 2011 26 32
112. L.E. Wagenknecht, E.J. Mayer, M. Rewers, S. Haffner, J. Selby, and G.M. Borok The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results Ann Epidemiol 5 1995 464 472
113. G. Zeng, and M.J. Quon Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells J Clin Invest 98 1996 894 898
114. H. Zhou, K.C. Tan, S.W. Shiu, and Y. Wong Cellular cholesterol efflux to serum is 399 impaired in diabetic nephropathy Diabetes Metab Res Rev 24 2008 617 623